These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37777848)

  • 1. Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.
    Walker JM; Orr ME; Orr TC; Thorn EL; Christie TD; Yokoda RT; Vij M; Ehrenberg AJ; Marx GA; McKenzie AT; Kauffman J; Selmanovic E; Wisniewski T; Drummond E; White CL; Crary JF; Farrell K; Kautz TF; Daoud EV; Richardson TE
    Alzheimers Dement; 2024 Feb; 20(2):783-797. PubMed ID: 37777848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration.
    Walker JM; Goette W; Farrell K; Iida MA; Karlovich E; ; White CL; Crary JF; Richardson TE
    Alzheimers Dement; 2023 Jul; 19(7):3158-3170. PubMed ID: 36738450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment.
    Marx GA; Koenigsberg DG; McKenzie AT; Kauffman J; Hanson RW; Whitney K; Signaevsky M; Prastawa M; Iida MA; White CL; Walker JM; Richardson TE; Koll J; Fernandez G; Zeineh J; Cordon-Cardo C; Crary JF; Farrell K;
    Acta Neuropathol Commun; 2022 Oct; 10(1):157. PubMed ID: 36316708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.
    Walker JM; Richardson TE; Farrell K; Iida MA; Foong C; Shang P; Attems J; Ayalon G; Beach TG; Bigio EH; Budson A; Cairns NJ; Corrada M; Cortes E; Dickson DW; Fischer P; Flanagan ME; Franklin E; Gearing M; Glass J; Hansen LA; Haroutunian V; Hof PR; Honig L; Kawas C; Keene CD; Kofler J; Kovacs GG; Lee EB; Lutz MI; Mao Q; Masliah E; McKee AC; McMillan CT; Mesulam MM; Murray M; Nelson PT; Perrin R; Pham T; Poon W; Purohit DP; Rissman RA; Sakai K; Sano M; Schneider JA; Stein TD; Teich AF; Trojanowski JQ; Troncoso JC; Vonsattel JP; Weintraub S; Wolk DA; Woltjer RL; Yamada M; Yu L; White CL; Crary JF
    J Neuropathol Exp Neurol; 2021 Jan; 80(2):102-111. PubMed ID: 33367843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
    Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
    Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauopathy: A common mechanism for neurodegeneration and brain aging.
    Saha P; Sen N
    Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
    Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
    Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
    Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    Llamas-Rodríguez J; Oltmer J; Greve DN; Williams E; Slepneva N; Wang R; Champion S; Lang-Orsini M; Fischl B; Frosch MP; van der Kouwe AJW; Augustinack JC
    J Alzheimers Dis; 2022; 87(3):1379-1399. PubMed ID: 35491780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
    Arner A; Rockenstein E; Mante M; Florio J; Masliah D; Salehi B; Adame A; Overk C; Masliah E; Rissman RA
    J Alzheimers Dis; 2018; 61(3):1201-1219. PubMed ID: 29332037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.
    Del Tredici K; Schön M; Feldengut S; Ghebremedhin E; Kaufman SK; Wiesner D; Roselli F; Mayer B; Amunts K; Braak H
    J Alzheimers Dis; 2024; 101(4):1333-1353. PubMed ID: 39302368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PART is part of Alzheimer disease.
    Duyckaerts C; Braak H; Brion JP; Buée L; Del Tredici K; Goedert M; Halliday G; Neumann M; Spillantini MG; Tolnay M; Uchihara T
    Acta Neuropathol; 2015 May; 129(5):749-56. PubMed ID: 25628035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.
    Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS
    Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure.
    Tsering W; Hery GP; Phillips JL; Lolo K; Bathe T; Villareal JA; Ruan IY; Prokop S
    Acta Neuropathol Commun; 2023 Dec; 11(1):190. PubMed ID: 38037144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.